ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000254341.1	Avagacestat	Bladder urothelial carcinoma	0.011431315	Resistant
ENSG00000254341.1	Avagacestat	Colon adenocarcinoma	0.032388699	Sensitive